BioSpace News Archive

University of Miami integrates Movendo Technology’s robotic system hunova© into baseline screening and physical rehabilitation of their student-athletes.

Results of a multicenter trial recently published in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists, demonstrated significant reductions in postoperative opioid use and pain following percutaneous peripheral nerve stimulation (PNS) compared to placebo.

- Pivotal Program Evaluated the Effects of Administering COSELA Prior to Chemotherapy on Clinically Relevant Endpoints Across Multiple Hematopoietic Lineages, Including Hematologic Adverse Events, Laboratory Values, and Use of Supportive Care Interventions - -

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021.

Helping improve patient outcomes by identifying and removing barriers to their care is just one reason AllianceRx Walgreens Prime and Highmark Inc. have joined forces to launch a social determinants of health pilot outreach program.

Himalaya Therapeutics today announced the appointment of Brian Zhang, Ph.D., as chief executive officer.

On 4 May, at 08:00 CEST, Swedish Orphan Biovitrum AB will publish its report for the first quarter 2021.

Advaxis, Inc. (NASDAQ: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that the Company has achieved the second milestone under its licensing agreement for ADXS31-164, also known as ADXS-HER2, to OS Therapies for evaluation in the treatment of osteosarcoma in humans.

LB Pharmaceuticals Inc, (“LB”) a biotechnology company focused on developing and commercializing novel and improved versions of successful CNS treatments, announced today that Zachary Prensky, President and Chief Executive Officer, will present at the 2021 B. Riley Securities’ Neuroscience Conference, to be held virtually on April 28-29, 2021.

James Lanthier, CEO of Mindset, commented, “Mindset is pleased to be invited to present at H.C. Wainwright’s conference.